semaglutide and mood Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis Neurodegenerative diseases: A Narrative Review | Pharmaceutical Research Semaglutide and Depression Risk: Clinical
Description
A 15% loss is very meaningful from a health perspective
Semaglutide is a medication that works by mimicking hormones that control blood sugar levels in people with diabetes
This is referred to as metabolic adaptation, which reduces GLP-1 and GIP levels and increases the orexigenic hormone ghrelin
You may be a good candidate for GLP-1 therapy if you: GLP-1 may not be recommended for those with certain endocrine conditions or a family history of medullary thyroid carcinoma
